Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)

NCT06919003 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

NIH

Sponsor class

Conditions

Kidney Transplant

Interventions

BIOLOGICAL: Berinert
OTHER: Placebo for Berinert

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)